Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction

Background We aimed to directly compare the diagnostic and prognostic performance of a dual maker strategy (DMS) with combined testing of copeptin and high-sensitivity (hs) cardiac troponin T (cTnT) it time of presentation with other algorithms for rapid rule-out of acute myocardial infarction (AMI)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Müller-Hennessen, Matthias (VerfasserIn) , Giannitsis, Evangelos (VerfasserIn) , Vafaie, Mehrshad (VerfasserIn) , Biener, Moritz (VerfasserIn) , Katus, Hugo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2019
In: International journal of cardiology
Year: 2018, Jahrgang: 276, Pages: 261-267
ISSN:1874-1754
DOI:10.1016/j.ijcard.2018.10.084
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.ijcard.2018.10.084
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0167527318339214
Volltext
Verfasserangaben:Matthias Mueller-Hennessen, Bertil Lindahl, Evangelos Giannitsis, Mehrshad Vafaie, Moritz Biener, Alexander C. Haushofer, Josef Seier, Michael Christ, Aitor Alquézar-Arbé, Christopher R. deFilippi, James McCord, Richard Body, Mauro Panteghini, Tomas Jernberg, Mario Plebani, Franck Verschuren, John K. French, Robert H. Christenson, Carina Dinkel, Hugo A. Katus, Christian Mueller, for the TRAPID-AMI investigators

MARC

LEADER 00000caa a2200000 c 4500
001 1587791293
003 DE-627
005 20220815105313.0
007 cr uuu---uuuuu
008 190219r20192018xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ijcard.2018.10.084  |2 doi 
035 |a (DE-627)1587791293 
035 |a (DE-576)517791293 
035 |a (DE-599)BSZ517791293 
035 |a (OCoLC)1341038316 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Müller-Hennessen, Matthias  |e VerfasserIn  |0 (DE-588)1058117955  |0 (DE-627)796417679  |0 (DE-576)414119061  |4 aut 
245 1 0 |a Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction  |c Matthias Mueller-Hennessen, Bertil Lindahl, Evangelos Giannitsis, Mehrshad Vafaie, Moritz Biener, Alexander C. Haushofer, Josef Seier, Michael Christ, Aitor Alquézar-Arbé, Christopher R. deFilippi, James McCord, Richard Body, Mauro Panteghini, Tomas Jernberg, Mario Plebani, Franck Verschuren, John K. French, Robert H. Christenson, Carina Dinkel, Hugo A. Katus, Christian Mueller, for the TRAPID-AMI investigators 
264 1 |c 2019 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Available online 26 October 2018 
500 |a Gesehen am 19.02.2019 
520 |a Background We aimed to directly compare the diagnostic and prognostic performance of a dual maker strategy (DMS) with combined testing of copeptin and high-sensitivity (hs) cardiac troponin T (cTnT) it time of presentation with other algorithms for rapid rule-out of acute myocardial infarction (AMI). Methods 922 patients presenting to the emergency department with suspected AMI and available baseline copeptin measurements qualified for the present TRAPID-AMI substudy. Diagnostic measures using the DMS (copeptin <10, <14 or<20pmol/L and hs-cTnT≤14ng/L), the 1h-algorithm (hs-cTnT<12ng/L and change <3ng/L at 1h), as well as the hs-cTnT limit-of-blank (LoB, <3ng/L) and -detection (LoD, <5ng/L) were compared. Outcomes were assessed as combined end-points of death and myocardial re-infarction. Results True-negative rule-out using the DMS could be achieved in 50.9%-62.3% of all patients compared to 35.0%, 45.3% and 64.5% using LoB, LoD or the 1h-algorithm, respectively. The DMS showed NPVs of 98.1%-98.3% compared to 99.2% for the 1h-algorithm, 99.4% for the LoB and 99.3% for the LoD. Sensitivities were 93.5%-94.8%, as well as 96.8%, 98.7% and 98.1%, respectively. Addition of clinical low-risk criteria such as a HEART-score≤3 to the DMS resulted in NPVs and sensitivities of 100% with a true-negative rule-out to 33.8%-41.6%. Rates of the combined end-point of death/MI within 30days ranged between 0.2% and 0.3% for all fast-rule-out protocols. Conclusion Depending on the applied copeptin cut-off and addition of clinical low-risk criteria, the DMS might be an alternative to the hs-cTn-only-based algorithms for rapid AMI rule-out with comparable diagnostic measures and outcomes. 
534 |c 2018 
650 4 |a Copeptin 
650 4 |a Dual-marker strategy 
650 4 |a High-sensitivity cardiac troponin T 
650 4 |a Rapid AMI rule-out 
700 1 |a Giannitsis, Evangelos  |e VerfasserIn  |0 (DE-588)113336241  |0 (DE-627)577184091  |0 (DE-576)289759579  |4 aut 
700 1 |a Vafaie, Mehrshad  |e VerfasserIn  |0 (DE-588)1032932163  |0 (DE-627)739736736  |0 (DE-576)380398710  |4 aut 
700 1 |a Biener, Moritz  |d 1983-  |e VerfasserIn  |0 (DE-588)101853119X  |0 (DE-627)682858374  |0 (DE-576)355963876  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cardiology  |d Amsterdam [u.a.] : Elsevier Science, 1981  |g 276(2019), Seite 261-267  |h Online-Ressource  |w (DE-627)306659581  |w (DE-600)1500478-8  |w (DE-576)081986270  |x 1874-1754  |7 nnas  |a Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction 
773 1 8 |g volume:276  |g year:2019  |g pages:261-267  |g extent:7  |a Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction 
856 4 0 |u http://dx.doi.org/10.1016/j.ijcard.2018.10.084  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0167527318339214  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190219 
993 |a Article 
994 |a 2019 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 20 
998 |g 101853119X  |a Biener, Moritz  |m 101853119X:Biener, Moritz  |d 910000  |d 910100  |e 910000PB101853119X  |e 910100PB101853119X  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1032932163  |a Vafaie, Mehrshad  |m 1032932163:Vafaie, Mehrshad  |d 910000  |d 910100  |e 910000PV1032932163  |e 910100PV1032932163  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 113336241  |a Giannitsis, Evangelos  |m 113336241:Giannitsis, Evangelos  |d 910000  |d 910100  |e 910000PG113336241  |e 910100PG113336241  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1058117955  |a Müller-Hennessen, Matthias  |m 1058117955:Müller-Hennessen, Matthias  |d 910000  |d 910100  |e 910000PM1058117955  |e 910100PM1058117955  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1587791293  |e 305619055X 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Matthias","role":"aut","display":"Müller-Hennessen, Matthias","roleDisplay":"VerfasserIn","family":"Müller-Hennessen"},{"family":"Giannitsis","roleDisplay":"VerfasserIn","given":"Evangelos","role":"aut","display":"Giannitsis, Evangelos"},{"family":"Vafaie","roleDisplay":"VerfasserIn","given":"Mehrshad","role":"aut","display":"Vafaie, Mehrshad"},{"family":"Biener","roleDisplay":"VerfasserIn","display":"Biener, Moritz","role":"aut","given":"Moritz"},{"given":"Hugo","display":"Katus, Hugo","role":"aut","family":"Katus","roleDisplay":"VerfasserIn"}],"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["Matthias Mueller-Hennessen, Bertil Lindahl, Evangelos Giannitsis, Mehrshad Vafaie, Moritz Biener, Alexander C. Haushofer, Josef Seier, Michael Christ, Aitor Alquézar-Arbé, Christopher R. deFilippi, James McCord, Richard Body, Mauro Panteghini, Tomas Jernberg, Mario Plebani, Franck Verschuren, John K. French, Robert H. Christenson, Carina Dinkel, Hugo A. Katus, Christian Mueller, for the TRAPID-AMI investigators"]},"relHost":[{"recId":"306659581","pubHistory":["1.1981 -"],"id":{"issn":["1874-1754"],"zdb":["1500478-8"],"eki":["306659581"]},"title":[{"title":"International journal of cardiology","title_sort":"International journal of cardiology"}],"disp":"Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarctionInternational journal of cardiology","note":["Gesehen am 13.02.20","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1981","dateIssuedDisp":"1981-","publisher":"Elsevier Science"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"276","text":"276(2019), Seite 261-267","pages":"261-267","year":"2019","extent":"7"}}],"language":["eng"],"origin":[{"dateIssuedDisp":"2019","dateIssuedKey":"2019"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction","title":"Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction"}],"id":{"eki":["1587791293"],"doi":["10.1016/j.ijcard.2018.10.084"]},"recId":"1587791293","note":["Available online 26 October 2018","Gesehen am 19.02.2019"]} 
SRT |a MUELLERHENCOMBINEDTE2019